<DOC>
	<DOC>NCT00611169</DOC>
	<brief_summary>The purpose of this study to investigate whether the administration of high-dose tirofiban before primary PCI could reduce myocardial infarct size, using analysis of contrast-enhanced magnetic resonance imaging.</brief_summary>
	<brief_title>The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<criteria>presence of chest pain for more than 30 minutes but less than 12 hours after symptom onset STsegment elevation more than 1 mm in two or more contiguous leads or presumably a newonset left bundle branch blockage hemodynamic instability history of MI old age &gt; 80years Patients with bleeding diathesis (coagulopathy, thrombocytopenia or platelet dysfunction, Gastrointestinal or genitourinary bleeding within the prior 3 months)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Angioplasty, Transluminal, Percutaneous Coronary</keyword>
	<keyword>tirofiban</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Myocardial Infarction</keyword>
</DOC>